drugset / Trial / NCT02199678
A Study to Assess the Analgesic Properties of a Sublingual Wafer Formulation of Ketamine Following Third Molar Extraction
RandomizedParallel-groupTriple-blindTreatment
Summary
This is a Phase 2, randomized, multicenter, parallel group, double-blind, dose-ranging, placebo-controlled evaluation of the analgesic efficacy, safety and pharmacokinetics of ketamine sublingual wafer in adult subjects who experience post operative pain after undergoing third molar extraction.
Timeline
- Start
- 2014-07
- Primary completion
- 2014-11
- Completion
- 2014-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Ketamine | Small molecule | 25 mg | Other |
| Comparator | Ketamine | Small molecule | 35 mg | Other |
| Comparator | Ketamine | Small molecule | 50 mg | Other |
Indications
No indication recorded.